These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 652997)

  • 21. [Dialyzability of possible "uremia toxins"].
    Brunner H; Brunner A
    Med Welt; 1976 Nov; 27(47):2264-6. PubMed ID: 12443
    [No Abstract]   [Full Text] [Related]  

  • 22. [Uremic toxin and dialysis].
    Nakagawa S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):430-2. PubMed ID: 988349
    [No Abstract]   [Full Text] [Related]  

  • 23. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 24. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 25. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 28. Heme synthesis in anemia of the uremic state.
    Linkesch W; Stummvoll HK; Wolf A; Müller M
    Isr J Med Sci; 1978 Nov; 14(11):1173-6. PubMed ID: 750546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uremic middle molecules: separation and quantitation.
    Chapman GV; Farrell PC
    Artif Organs; 1981; 4 Suppl():160-5. PubMed ID: 7295084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uremic toxin and dialysis].
    Kobayashi K; Maeda K; Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):412-4. PubMed ID: 988343
    [No Abstract]   [Full Text] [Related]  

  • 31. A potent inhibitor of cell proliferation in "middle molecules" isolated from the urine of uremic patients.
    Navarro J; Gerlier D; Touraine JL; Later R; Contreras P; Dore JF; Traeger J
    Biomedicine; 1979 Dec; 31(9-10):261-4. PubMed ID: 543928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Uremic toxins].
    Lutz W
    Postepy Hig Med Dosw; 1978; 32(2):245-64. PubMed ID: 704491
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibitory mechanism of platelet energy production and platelet functions by PGE1 and uremic toxins (author's transl)].
    Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):477-87. PubMed ID: 4799441
    [No Abstract]   [Full Text] [Related]  

  • 35. Uremic toxins inhibit the platelet malonyldialdehyde production rate.
    Tanaka H; Itoh S; Yamagami S; Kishimoto T; Maekawa M; Ringoir S
    Adv Exp Med Biol; 1987; 223():115-8. PubMed ID: 3447425
    [No Abstract]   [Full Text] [Related]  

  • 36. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.